These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10588573)

  • 1. Neuronal loss and beta-amyloid removal in the amygdala of people with Down syndrome.
    Weģiel J; Wísniewski HM; Moryś J; Tarnawski M; Kuchna I; Dziewiatkowski J; Pirttilä T; Krivimäki T; Lehtimäki T; Lach B
    Neurobiol Aging; 1999; 20(3):259-69. PubMed ID: 10588573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Entorhinal cortex of aged subjects with Down's syndrome shows severe neuronal loss caused by neurofibrillary pathology.
    Sadowski M; Wisniewski HM; Tarnawski M; Kozlowski PB; Lach B; Wegiel J
    Acta Neuropathol; 1999 Feb; 97(2):156-64. PubMed ID: 9928826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrillar amyloid-beta affects neurofibrillary changes but only in neurons already involved in neurofibrillary degeneration.
    Wegiel J; Bobinski M; Tarnawski M; Dziewiatkowski J; Popovitch E; Miller DC; Wisniewski T; Golomb J; de Leon MJ; Reisberg B
    Acta Neuropathol; 2001 Jun; 101(6):585-90. PubMed ID: 11515787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibrillary Tangles of Aβx-40 in Alzheimer's Disease Brains.
    Lacosta AM; Insua D; Badi H; Pesini P; Sarasa M
    J Alzheimers Dis; 2017; 58(3):661-667. PubMed ID: 28453491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease. The density of amygdalar neuritic plaques is associated with the severity of neurofibrillary pathology and the degree of beta-amyloid protein deposition in the cerebral cortex.
    Yilmazer-Hanke DM
    Acta Anat (Basel); 1998; 162(1):46-55. PubMed ID: 9789108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraneuronal Abeta immunoreactivity is not a predictor of brain amyloidosis-beta or neurofibrillary degeneration.
    Wegiel J; Kuchna I; Nowicki K; Frackowiak J; Mazur-Kolecka B; Imaki H; Wegiel J; Mehta PD; Silverman WP; Reisberg B; Deleon M; Wisniewski T; Pirttilla T; Frey H; Lehtimäki T; Kivimäki T; Visser FE; Kamphorst W; Potempska A; Bolton D; Currie JR; Miller DL
    Acta Neuropathol; 2007 Apr; 113(4):389-402. PubMed ID: 17237937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome.
    Gyure KA; Durham R; Stewart WF; Smialek JE; Troncoso JC
    Arch Pathol Lab Med; 2001 Apr; 125(4):489-92. PubMed ID: 11260621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laminar specific loss of isocortical presenilin 1 immunoreactivity in Alzheimer's disease. Correlations with the amyloid load and the density of tau-positive neurofibrillary tangles.
    Colle MA; Duyckaerts C; Laquerrière A; Pradier L; Czech C; Checler F; Hauw JJ
    Neuropathol Appl Neurobiol; 2000 Apr; 26(2):117-23. PubMed ID: 10840274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The possible place of cathepsins and cystatins in the puzzle of Alzheimer disease: a review.
    Bernstein HG; Kirschke H; Wiederanders B; Pollak KH; Zipress A; Rinne A
    Mol Chem Neuropathol; 1996 Apr; 27(3):225-47. PubMed ID: 9147410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability of beta-amyloid protein deposited lesions in Down's syndrome brains.
    Ikeda S; Tokuda T; Yanagisawa N; Kametani F; Ohshima T; Allsop D
    Tohoku J Exp Med; 1994 Nov; 174(3):189-98. PubMed ID: 7761984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
    Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
    Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HNE-modified proteins in Down syndrome: Involvement in development of Alzheimer disease neuropathology.
    Barone E; Head E; Butterfield DA; Perluigi M
    Free Radic Biol Med; 2017 Oct; 111():262-269. PubMed ID: 27838436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo reversal of amyloid-beta lesions in rat brain.
    Sigurdsson EM; Permanne B; Soto C; Wisniewski T; Frangione B
    J Neuropathol Exp Neurol; 2000 Jan; 59(1):11-7. PubMed ID: 10744031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse Amyloid-β Plaques, Neurofibrillary Tangles, and the Impact of APOE in Elderly Persons' Brains Lacking Neuritic Amyloid Plaques.
    Abner EL; Neltner JH; Jicha GA; Patel E; Anderson SL; Wilcock DM; Van Eldik LJ; Nelson PT
    J Alzheimers Dis; 2018; 64(4):1307-1324. PubMed ID: 30040735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of Alzheimer-related neuritic plaque pathology in the entorhinal region, perirhinal cortex and hippocampal formation.
    Yilmazer-Hanke DM; Hanke J
    Dement Geriatr Cogn Disord; 1999; 10(2):70-6. PubMed ID: 10026378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
    van de Nes JA; Nafe R; Schlote W
    Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice.
    Ribé EM; Pérez M; Puig B; Gich I; Lim F; Cuadrado M; Sesma T; Catena S; Sánchez B; Nieto M; Gómez-Ramos P; Morán MA; Cabodevilla F; Samaranch L; Ortiz L; Pérez A; Ferrer I; Avila J; Gómez-Isla T
    Neurobiol Dis; 2005 Dec; 20(3):814-22. PubMed ID: 16125396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau pathology in diffuse neurofibrillary tangles with calcification (DNTC): biochemical and immunohistochemical investigation.
    Tanabe Y; Ishizu H; Ishiguro K; Itoh N; Terada S; Haraguchi T; Kawai K; Kuroda S
    Neuroreport; 2000 Aug; 11(11):2473-7. PubMed ID: 10943706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
    Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H
    Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
    Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
    Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.